CDC published Interim Estimates of 20242025 COVID-19 Vaccine Effectiveness Among Adults Aged 18 Years VISION and IVY Networks, September 2024January 2025 in MMWR on February 27, 2025 (www.cdc.gov/mmwr/volumes/74/wr/mm7406a1.htm)
Quickstart Highlights Cagrilintide is a long-acting amylin analog studied for appetite control and weight management [1] it imitates the satiety hormone amylin to blunt hunger and slow gastric emptying [2]
Efficacy-wise, AOD-9604 produces modest results (2-3 kg over 12 weeks in trials) compared to GLP-1 agonists dramatic weight loss
Oral forms (capsules, sprays, or drops) are easier to administer
This stability partially explains why both nasal and oral administration routes remain viable options for delivery
Additionally, it activates calcitonin receptor and receptor activity-modifying protein complexes